Introduction {#s1}
============

In China, a vertical networking system for non-communicable disease prevention and control has been well-established, in which national, provincial, municipal, and local Health Commissions; the Centers for Disease Control and Prevention (CDC); offices for specific disease control; hospitals; and Community Healthcare Service Centers (CHSC) are supposed to work together to fight against non-communicable diseases ([@B1]). At the county/district level, a tree-like structured healthcare system was also established, with local CDC, CHSC, and medical centers working as functional units for comprehensive healthcare services under the administration of the local Health Commission ([Figure 1](#F1){ref-type="fig"}). Due to lacking health information sharing platform, however, health information and health records could not be exchanged and shared among these executive institutions. As a result, health services offered by different institutions, from primary to tertiary, were not effectively integrated.

![Institutional infrastructure of disease control system and cancer care services in China. Frame: Functional units of county/district-level institutions that practice the basic services.](fonc-09-00375-g0001){#F1}

Cancer care provided at the county/district level is a typical example of separated public service delivery: health education and screening programs are usually organized by local CDCs, while clinical diagnosis and treatment of cancers are performed by local medical centers and community-based check-up and post-treatment services are provided by CHSCs ([@B2]). Due to a lack of a referral system, these institutions remain distinct and independent from each other. Only in limited areas where the cancer registry system is well-established will medical centers report newly diagnosed cancer cases to a local cancer registry system, from which the local CDC and CHSCs can be alerted of occurrence of the disease and then provide standardized health care to the patients ([@B3]). However, this happens in the absence of detailed feedbacks and technical supports from medical centers for specific and individualized patient care.

To solve the problem, Minhang District, one of the 18 administrative districts in Shanghai, China, established an electronic health record (e-HR) system in 2005. The system has been used to comprehensively deliver various health services and improve accessibility and quality of services ([@B4]). In 2008, Minhang district initiated a comprehensive cancer screening program based on the e-HR system ([@B5]), aimed to improve the effectiveness and efficacy of cancer screening with a seamless interface of government machinery.

In this article, we introduced the 9-year experience of the e-HR-based cancer screening and health management for detected cancer cases and individuals at high risk and thus provide recommendations for seamless service delivery in the real world.

Materials and Methods {#s2}
=====================

This study was chosen as a prospective design, based on the constructive analysis of key information, organizations, and observations of cancer screening, stages of cancers detected by the e-HR-based programs, and healthcare processes for high-risk population.

The study material was the process and results of the e-HR-based screening programs for six major cancers, i.e., colorectal cancer, gastric cancer, liver cancer, lung cancer, cervical cancer, and breast cancer, among residents in Minhang District of Shanghai, China. All data for this study were extracted from the established e-HR system. The study was approved by the Institutional Review Board of Minhang District CDC (NO: EC-P-2012-002). Verbal informed consent was obtained from each participant of the cancer screening program.

Electronic Health Record System in Minhang District
---------------------------------------------------

The Minhang e-HR system is a comprehensive information platform integrating primary care, medical or clinical records, vaccine inoculation, and other public health activities ([Figure 2](#F2){ref-type="fig"}). It is administrated by the Health Commission of Minhang District and executed by the CDC of Minhang District. All CHSCs and medical centers in the district were organized and interlinked within the system.

![Administrative and institutional infrastructure of electronic health record (e-HR)-based early detection and continuous health management for six major cancers in Minhang district of Shanghai, China.](fonc-09-00375-g0002){#F2}

All residents in Minhang District have a medical care card implanted with a microchip, through which their medical records and healthcare information are recordable and accessible by responsible doctors in all local health institutions, including CHSCs and medical centers in the district. The information is also accessible by staff in CDC by logging in the e-HR system. There are three major functions of the e-HR system: (1) to report and evaluate medical records, (2) to feedback clinical results and conduct follow-up, and (3) to provide mutual referral service.

The Minhang e-HR system was established in 2005 and covered 93.05% (*n* = 830,400) of the local permanent residents and 30.5% (*n* = 334,800) of a migrant population in 2014 ([@B6]). So far, the e-HR system has included information for over 2.6 million people, covering almost all residents in the district.

Comprehensive Electronic Health Record-Based Cancer Prevention Programs
-----------------------------------------------------------------------

The cancer prevention programs in Minhang District are a series of comprehensive healthcare services provided based on the established e-HR system. Three major modules were included in the e-HR system to promote accessibility and implementation of the early detection of cancers: (1) health education on cancer prevention. Usually, training courses on cancer prevention were delivered by general practitioners in CHSCs for residents aged over 40 years. These residents were asked to record their attendance in any courses in the e-HR system by scanning their medical care card; (2) free health check-up programs, including health check-up for senior residents over 60 years, "two cancer" (breast and cervical cancer) screening for vulnerable women population, and health check-up for rural residents. The subjects could be identified through the e-HR system; and (3) opportunistic screening in all local clinics and medical centers. Physicians involving in the program were reminded by the e-HR system automatically to provide free cancer screening for those who had certain risk factors, related symptoms, or claims.

Application of Electronic Health Record System in Cancer Risk Assessment
------------------------------------------------------------------------

In all health institutions, the recruited residents were asked to answer whether they had (1) cancer-related symptoms like changed shape/property of feces, phlegmatically blood feces, abdominal pain, hematemesis, anemia, cough or expectoration sputum, abnormal vaginal secretions (women only), abnormal nipple discharge (women only), etc.; (2) precancerous lesions, such as digest duct polyps, adenomas, gastric intestinal metaplasia, atrophic gastritis, or cervical intraepithelial neoplasia (women only), etc.; (3) family history of the six major cancers; (4) occupational exposures to radon, arsenic, chromium, nickel, or asbestos; (5) cigarette smoking; (6) infections with HBV, HCV, HPV, or other cancer-related pathogens; (7) infertility (women only); and (8) use of estrogens or oral contraceptives (women only).These information were entered into the e-HR system, based on which individuals\' risks for the six major cancers could be evaluated by all health institutes involved according to the criteria predefined based on the guidelines ([@B7], [@B8]) or previous studies ([@B9]--[@B15]).

Application of Electronic Health Record System in Cancer Screening
------------------------------------------------------------------

Individuals with positive results in risk assessment were referred to receiving respective free initial screening tests. The testing results, both negative and positive, were entered into the e-HR system by staffs in CHSCs and could be accessed by staff in Minhang CDC through logging in the system and by doctors in secondary or tertiary medical centers using patients\' medical care cards implanted with a microchip.

Referral, Follow-Up, and Information Exchange
---------------------------------------------

A mutual referral and information exchange mechanism between CHSCs and secondary or tertiary medical centers was also established within the framework of e-HR system ([Figure 2](#F2){ref-type="fig"}). For example, if a resident was negative in cancer screening tests but evaluated to be at high risk of cancer, he/she would be referred to secondary or tertiary medical centers in Minhang District for further clinical examinations. On the other hand, if a resident was positive in cancer screening tests, he/she would be visited by a CHSC doctor within 1 month for community-based primary care and a physician in medical centers for clinical follow-up and medical care. The whole process and results of questionnaire-based risk assessment, screening, community and clinical follow-up, and health management were electronically recorded and centralized in the district-level database and were available for all health institutions in the district.

For newly diagnosed cancer cases, an effective referral mechanism ensures information exchange between local and municipal Cancer Registry System. Once a permanent resident in Minhang District was diagnosed with cancer in hospitals in the district, his/her information would be reported to the local Cancer Registry System first and then to the Shanghai Municipal Cancer Registry. On the contrary, if a permanent resident of Minhang District was first diagnosed with cancer outside the district, his/her information would be reported to the Shanghai Municipal Cancer Registry System first and then was recognized and added to the e-HR database and local Cancer Registry by the CDC of Minhang District. Thereby, the information of all cancer cases could be accessible for designated continuous clinical follow-up and health management by local institutes.

Continuous Health Management for High-Risk Individuals
------------------------------------------------------

Targeted residents who met either of the following two criteria were identified as high-risk individuals: (1) with a positive result in initial screening tests but a negative result in diagnostic tests and (2) with a family history of any cancer or a precancerous lesion. For this population, doctors at CHSCs were designated to provide primary care and follow-up services per month, which include health education, behavioral interventions and routine clinical tests, and if necessary, referral advices for further qualified diagnosis and clinical care in medical centers ([Figure 3](#F3){ref-type="fig"}).

![Reporting process of e-HR-based early detection for six major cancers in Minhang District of Shanghai, China, 2008--2016. Solid arrow: resident flow; dashed arrow: information flow.](fonc-09-00375-g0003){#F3}

Data Analysis
-------------

Descriptive analyses were performed by presenting the number and percentage of residents in each subgroup. Chi-square tests were used to compare proportions of early-stage cancers among those screen-detected, identified by follow-up or diagnosed by clinic visits. The trend analysis was conducted by using *p*-values for row mean score differences in Cochran--Mantel--Haenszel statistics. A *p-*value of \< 0.05 was considered as statistically significant. SPSS 11.0 software was used in all data analyses.

Results {#s3}
=======

[Table 1](#T1){ref-type="table"} presents the criteria to identify eligible subjects for initial cancer screening tests based on e-HR system. All residents over 40 years in Minhang district were eligible for colorectal cancer and gastric cancer screening programs. For liver cancer and lung cancer screening, only those with positive results in risk assessment were recruited. For cervix uteri cancer and breast cancer screening, all women over 40 years receiving free health check-up were included, while only those with positive results in risk assessment were recruited in CHSCs and medical centers.

###### 

Criteria used to define high-risk individuals in electronic health record (e-HR)-based risk assessment in Minghang District of Shanghai, China.

  **Cancer site**                                 **Criteria used to define high-risk individuals**             
  ----------------------------------------------- ------------------------------------------------------------- ---------------
  Colorectum                                      Over 40 years                                                 
  Stomach                                         Over 40 years                                                 
  Liver                                           Positive in risk assessment[^†^](#TN1){ref-type="table-fn"}   
  Lung                                            Positive in risk assessment[^†^](#TN1){ref-type="table-fn"}   
  Cervix uteri [^‡^](#TN1){ref-type="table-fn"}   Positive in risk assessment[^†^](#TN1){ref-type="table-fn"}   Over 40 years
  Breast [^‡^](#TN1){ref-type="table-fn"}         Positive in risk assessment[^†^](#TN1){ref-type="table-fn"}   Over 40 years

*CHSC, Community Healthcare Service Center*.

*With related family history, risk behaviors, or symptoms*.

*Only for women*.

As shown in [Table 2](#T2){ref-type="table"}, subjects identified with high risk of respective cancers received fecal occult blood test (FOBT) and/or rectal exam as initial screening tests for colorectal cancer, had FOBT for gastric cancer, alpha-fetoprotein (AFP) and ultrasonic testing for liver cancer, chest X-ray for lung cancer, Pap smears for cervix uteri cancer, and clinical breast examination (CBE) and thermal texture maps (TTMs) for breast cancer. These tests, as well as tumor-associated antigen test, mammography, low-dose computerized tomography, colonoscopy, gastroscopy, or colposcopy, were further provided for those with negative results in diagnostic tests or those with a family history of cancer or precancerous lesion as a continuous health management service.

###### 

Initial screening tests used in e-HR-based cancer screening programs in Minhang District of Shanghai, China.

  **Cancer site**   **Initial screening tests used in subgroups**   **Continuous health management services[^†^](#TN3){ref-type="table-fn"}**                 
  ----------------- ----------------------------------------------- --------------------------------------------------------------------------- ------------- ---------------------------------------------
  Colorectum        FOBT                                            FOBT + RE                                                                   FOBT          Colonoscopy[^‡^](#TN4){ref-type="table-fn"}
  Stomach           FOBT                                            FOBT                                                                        FOBT          Gastroscopy
  Liver             AFP + UT                                        AFP + UT                                                                    AFP + UT      AFP + UT
  Lung              Chest X-ray                                     Chest X-ray                                                                 Chest X-ray   Chest X-ray or LDCT
  Cervix uteri      Pap smear                                       Pap smear                                                                   Pap smear     Pap smear + colposcopy
  Breast            CBE + TTM                                       CBE + TTM                                                                   CBE + TTM     MAM or UT

*CHSC, Community Healthcare Service Center; FOBT, fecal occult blood test; RE, rectal exam; AFP, alpha-fetoprotein; UT, ultrasonic testing; LDCT, low-dose computerized tomography; CBE, clinical breast examination; TTM, thermal texture maps; MAM, mammography*.

*Only for individuals with a negative result in diagnostic tests or with a family history of any cancer or having a precancerous lesion*.

*FOBT or RE for some subjects*.

During the period of 2008 to 2016, the proportion of targeted residents receiving questionnaire-based risk evaluation increased from 3.1 to 22.2% for colorectal cancer (*p* for trend \< 0.01), from 1.6 to 23.0% for gastric cancer (*p*-trend \< 0.01), from 7.3 to 20.5% for liver cancer (*p* trend \< 0.01), and from 1.8 to 21.2% for lung cancer (*p* trend \< 0.01) ([Table 3](#T3){ref-type="table"}). The proportion also increased for cervix uteri cancer and breast cancer from 2008 to 2014 but decreased in 2015.

###### 

Cancers and high-risk individuals identified in e-HR-based cancer screening programs in Minhang District of Shanghai, China, 2008--2016.

  **Cancer site**                                    **Calendar year**   **All subjects**   **Participants of e-HR-based cancer screening programs**                                                     
  -------------------------------------------------- ------------------- ------------------ ---------------------------------------------------------- ------ --------- ------- ------- ------ --------- --------
  **COLORECTUM**                                                                                                                                                                                         
                                                     2008                491,853            476                                                        3.1    15,351    924     34      7.1    1,151     --
                                                     2009                511,366            567                                                        18.6   76,407    1,647   84      14.8   3,225     1,065
                                                     2010                469,691            569                                                        24.6   115,630   2,854   119     20.9   1,838     3,574
                                                     2011                549,318            527                                                        21.3   117,039   1,883   98      18.6   1,337     7,765
                                                     2012                563,525            512                                                        34.4   193,654   5,678   164     32.0   4,260     11,153
                                                     2013                577,892            639                                                        32.3   186,391   7,350   183     28.6   5,075     10,800
                                                     2014                592,322            598                                                        29.5   174,581   6,888   160     26.8   3,109     20,409
                                                     2015                606,961            640                                                        22.2   134,790   6,181   124     19.4   2,322     21,555
                                                     2016                623,788            628                                                        22.2   138,445   8,861   112     17.8   1,961     18,446
  **STOMACH**                                                                                                                                                                                            
                                                     2008                491,853            417                                                        1.6    8,035     206     12      2.9    924       --
                                                     2009                511,366            393                                                        15.5   79,342    781     49      12.5   1,198     686
                                                     2010                469,691            403                                                        25.6   120,104   2,190   86      21.3   1,402     3,634
                                                     2011                549,318            385                                                        22.3   122,557   1,522   73      19.0   1,126     8,251
                                                     2012                563,525            331                                                        36.2   203,723   4,000   106     32.0   2,325     9,697
                                                     2013                577,892            454                                                        33.6   194,343   5,234   126     27.8   1,862     18,485
                                                     2014                592,322            420                                                        30.6   181,057   5,190   127     30.2   1,676     23,261
                                                     2015                606,961            462                                                        23.4   142,288   4,552   65      14.1   1,127     11,200
                                                     2016                623,788            483                                                        23.0   143,236   8,619   84      17.4   1,863     10,462
  **LIVER**                                                                                                                                                                                              
                                                     2008                491,853            251                                                        7.3    15,181    52      14      5.6    481       --
                                                     2009                511,366            242                                                        16.4   3,448     15      9       3.7    2,152     291
                                                     2010                469,691            280                                                        24.0   6,376     99      10      3.6    695       3,479
                                                     2011                549,318            214                                                        20.4   2,335     24      9       4.2    914       5,463
                                                     2012                563,525            153                                                        36.0   3,367     87      10      6.5    1,673     8,275
                                                     2013                577,892            242                                                        31.2   2,651     36      4       1.7    1,435     10,913
                                                     2014                592,322            264                                                        28.3   2,243     27      14      5.3    760       5,213
                                                     2015                606,961            265                                                        20.5   2,061     35      3       1.1    672       7,864
                                                     2016                623,788            270                                                        20.5   2,104     41      6       2.2    1,206     7,678
  **LUNG**                                                                                                                                                                                               
                                                     2008                491,853            609                                                        1.8    1,867     43      15      2.5    593       --
                                                     2009                511,366            677                                                        16.1   56,215    215     79      11.7   3,787     436
                                                     2010                469,691            667                                                        24.5   30,622    237     89      13.3   4,346     4,221
                                                     2011                549,318            577                                                        22.0   20,868    265     45      7.8    3,473     13,021
                                                     2012                563,525            547                                                        37.8   25,605    1,246   54      9.9    8,152     18,799
                                                     2013                577,892            899                                                        32.0   22,350    949     48      5.3    6,909     8,423
                                                     2014                592,322            984                                                        28.6   19,258    633     71      7.2    6,144     4,868
                                                     2015                606,961            1070                                                       21.9   19,441    695     55      5.1    5,410     37,498
                                                     2016                623,788            923                                                        21.2   19,473    1,152   45      4.9    5,965     36,105
  **CERVIX UTERI**[^†^](#TN6){ref-type="table-fn"}                                                                                                                                                       
                                                     2008                245,435            44                                                         16.8   2,727     60      1       2.3    4,810     --
                                                     2009                255,753            67                                                         18.8   15,309    134     13      19.4   3,261     6,322
                                                     2010                266,289            66                                                         23.9   53,763    1,439   16      24.2   691       8,948
                                                     2011                275,492            62                                                         21.4   39,001    3,379   10      16.1   1,338     3,430
                                                     2012                282,763            79                                                         29.3   48,349    4,485   22      27.8   1,506     4,110
                                                     2013                290,167            74                                                         25.3   41,384    1,736   22      29.7   1,767     5,839
                                                     2014                297,616            124                                                        23.6   45,698    2,132   42      33.9   1,730     7,544
                                                     2015                305,206            140                                                        14.8   29,018    1,364   27      19.3   2,591     18,757
                                                     2016                314,008            145                                                        18.2   41,706    1,374   50      34.5   2,909     20,430
  **BREAST**[^†^](#TN6){ref-type="table-fn"}                                                                                                                                                             
                                                     2008                245,435            333                                                        16.9   6,407     1,796   24      7.2    2,799     1,862
                                                     2009                255,753            318                                                        18.3   10,258    2,493   21      6.6    5,683     9,196
                                                     2010                266,289            356                                                        25.2   58,237    6,841   47      13.2   3,930     15,329
                                                     2011                275,492            361                                                        21.7   45,393    7,804   62      17.2   1,602     11,839
                                                     2012                282,763            371                                                        28.5   47,580    4,585   58      15.6   2,340     12,531
                                                     2013                290,167            380                                                        23.4   40,154    1,976   41      10.8   3,564     16,601
                                                     2014                297,616            413                                                        21.7   44,402    1,424   50      12.1   979       16,526
                                                     2015                305,206            362                                                        13.5   27,876    1,035   27      7.5    1,006     23,522
                                                     2016                314,008            395                                                        16.9   37,564    1,318   29      7.3    1,501     22,278
  Total                                                                                     22,182                                                                              2,948          136,555   

*Only for women; Data in 2008 were incomplete for cervix uteri cancer*.

A total of 24,278 residents over 40 years old were identified at high risk of colorectal cancer, 13,503 for stomach cancer, 9,988 for liver cancer, 44,779 for lung cancer, 20,603 for cervix uteri cancer, and 23,404 for breast cancer. All these subjects were registered into the high-risk population management database and offered with regular community-based primary care mentioned earlier.

As shown in [Table 4](#T4){ref-type="table"}, a total of 2,948 cancer cases were detected through the e-HR system, accounting for 13.3% of all 22,182 newly diagnosed cancer cases in Minhang District. The proportions of early-stage cancers through identified e-HR system, both by screening and by subsequent follow-up, were significantly higher than those through regular medical practices (all *p* \< 0.0001).

###### 

Comparison of cancer cases detected by e-HR-based programs and by clinical visits in Minhang District of Shanghai, China, 2008--2016.

  **Cancer site**                                **Identified in cancer screening programs**   **Identified by subsequent follow-up**   **Diagnosed by clinical visits**   ***p-*values for *x*^**2**^ tests**                                          
  ---------------------------------------------- --------------------------------------------- ---------------------------------------- ---------------------------------- ------------------------------------- ------- ------ -------- ------- ------ -----------
  Colorectum                                     1,078                                         311                                      28.8                               1,677                                 254     15.1   2,401    182     7.6    \< 0.0001
  Stomach                                        728                                           150                                      20.6                               939                                   135     14.9   2,081    276     13.3   \< 0.0001
  Liver                                          79                                            16                                       20.3                               200                                   15      7.5    1,902    120     6.3    \< 0.0001
  Lung                                           501                                           79                                       15.0                               1,524                                 198     13.0   4,928    566     11.5   \< 0.0001
  Cervix uteri[^†^](#TN7){ref-type="table-fn"}   203                                           168                                      82.8                               329                                   264     80.2   269      57      21.2   \< 0.0001
  Breast[^†^](#TN7){ref-type="table-fn"}         359                                           182                                      50.7                               871                                   401     46.0   2,059    681     33.1   \< 0.0001
  Total                                          2,948                                         906                                      30.7                               5,540                                 1,267   22.9   13,640   1,882   13.8   

*Cases with TNM staging 0--II for colorectal, gastric, liver, and lung cancers, at stage 0--IIa under FIGO 2,000 classification for cervical cancer, and with TisN0M0/T1N0M0 and primary tumor diameter ≤ 2 cm for breast cancer*.

Discussion {#s4}
==========

In Minhang district of Shanghai, China, with over 950,000 residents and over 530,000 residents aged more than 40 years (<http://www.shmh.gov.cn/>, accessed on Jan 16, 2019), an infrastructure for e-HR-based cancer screening was well-established and a series of screening programs have been implemented effectively to detect major cancers over the past several years, particularly for colorectal cancer, gastric cancer, liver cancer, lung cancer, cervical cancer, and breast cancer. This, to the best of our knowledge, is the first e-HR-based comprehensive health practice in cancer prevention at district/city level, which is regarded as a local level exploration for healthcare reform in China. Currently, the system has achieved a capability of offering relevant services for over 20% of population aged 40 years or above each year.

Comprehensive e-HR systems have been successfully applied in many European countries ([@B16]--[@B18]) and partly in the United States such as Kaiser Permanente ([@B19]) and Veterans Affairs Health Care ([@B20]). The successful models of organizing and operating e-HR systems provide platforms for cancer screening in resource-rich settings ([@B21]--[@B25]). In China, a middle-income country, the e-HR system has been used to identify patterns of non-communicable diseases ([@B26]), evaluate effect of an intervention in patients with chronic obstructive pulmonary disease ([@B27]), and improve cardiovascular care and outcome ([@B28]). The present program, taking advantages of the e-HR system, successfully identified a higher proportion of early-stage cancers than regular medical services, offering an example of applying the e-HR system as a feasible comprehensive cancer care system in resource-limited settings.

Our results also suggest that the e-HR system in Minhang District is not only a surveillance system but also a useful platform for health education and health promotion. Health education as a primary prevention strategy is delivered to all community participants at the very beginning, followed by disease screening as the secondary prevention and where appropriate, post-treatment follow-up and health management as the tertiary service. Furthermore, the e-HR system seems useful for identifying health needs in local settings. For instance, the present program has reached a fairly comparable coverage for colorectal, breast, and cervical cancers with screening programs in the United States ([@B29]), but only limited screening services were provided for liver cancer and lung cancer due to the relatively high cost but low sensitivity of the initial screening tests like AFP test, ultrasonic, and chest X-ray examinations.

Evidently, the e-HR system has the potential to extend the accessibility of healthcare services in the general population by coordinating and integrating various healthcare services efficiently. In this case, health services for cancer screening, from risk evaluation, early detection of cancer cases, to post-treatment follow-up and health management, were provided efficiently by multiple institutes based on the e-HR system.

Experiences and lessons also can be learned from this program for sustaining a public health system, which may balance increasing challenges and health needs. The e-HR system requires a team approach to input, analyze, and implement huge data. The doctors in CHSCs and medical centers act as the driving force behind the system, but advanced practice clinicians, nurses, quality coordinators, information technology support, and many others should collaborate to make it successful. In most developing countries, however, limited investment in public health and shortage of medical resources remain a big issue. However, the investment in e-HR system will save public health resources in the long run. As a typical example, Minhang District is a rapidly developing region with limited public health budget. Local annual budget for public health and disease prevention is only 100 Yuan RMB per person (1 US dollar equals about 6.8 Yuan RMB), which cannot cover a universal screening for all kinds of chronic diseases, including cancer. Based on the e-HR system, however, the present early cancer detection and continuous service program costs only about 10% of the annual public health budget for risk assessment, screening, subsidies for clinical check-ups, and health management for high risk people. With possibly increased public health budget in the coming years in Minhang District, it is very likely and foreseeable to extend the program from cancer to other non-communicable diseases. Moreover, the e-HR data can be accessed and used by any researchers once their applications are approved by local Health Commissions, which provide valuable opportunities for further scientific researches.

There are several limitations of this study. First, we did not compare the characteristics of participants and non-participants of the cancer screening program. The potential differences between the two subpopulations may have biased our results. Second, we did not take the sensitivities and specificities of cancer screening methods used in the population into consideration. Several methods with low validity such as CBE, TTM, AFP, and chest X-ray were used in the program, leading to unnecessary costs. Finally, cost-effective analysis of the program was not conducted due to lack of financial data for e-HR system building, limiting our ability to evaluate the system.

Conclusions {#s5}
===========

In conclusion, the e-HR system in Minhang District enables local health institutions to provide integrative and comprehensive health care and management for cancers. The successful application of an e-HR system in cancer prevention and control implies that the system may act as an extendable and sustainable infrastructure for comprehensive health care and services for a broad spectrum of diseases and health events.
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e-HR

:   electronic health records

CDC

:   Centers for Disease Control and Prevention

CHSC

:   Community Healthcare Service Centers

FOBT

:   fecal occult blood test

RE

:   rectal exam

TAA

:   tumor-associated antigens

AFP

:   alpha-fetoprotein

UT

:   ultrasonic testing

LDCT

:   low-dose computerized tomography

CBE

:   clinical breast examination

TTM

:   thermal texture maps

MAM

:   mammography.
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